Unlisted
| Company Name | (주)큐라티스 |
| English Name | Quratis Inc. |
| Business Reg. No. | 4028614683 |
| CEO | 김성준 |
| Address | 충청북도 청주시 흥덕구 오송읍 의료단지길 143 - |
| Industry | 합성의약품 및 기타 완제 의약품 제조업 |
| Industry Code | 70113 |
| Main Products | 결핵백신 |
| Established | Contact |
| Phone | 070-4141-5942 |
| Website | quratis.com |
| Regular Employees | 42persons |
| Corp. Reg. No. | 1101116122983 |
Venture Certified
| 벤처투자유형 | 2017-11-23 ~ 2019-11-22 | 20170300644 | 2017-11-23 |
| 벤처투자유형 | 2019-11-23 ~ 2021-11-22 | 20190301110 | 2017-11-23 |
| 벤처투자유형 | 2021-11-23 ~ 2024-11-22 | 20211110010061 | 2017-11-23 |
| 벤처투자유형 | 2024-11-23 ~ 2027-11-22 | 20241113010045 | 2017-11-23 |
Revenue CAGR -38.3%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 3.7B | 10.3B | 75.2B | 15.9B |
| Operating Profit | -197.2B | -169.3B | -232.9B | -169.8B |
| Net Profit | -262.7B | -169.9B | -372.2B | -203.8B |
| Total Assets | 466.5B | 672.0B | 649.0B | 818.7B |
| Total Liabilities | 261.7B | 310.8B | 917.4B | 734.7B |
| Total Equity | 204.8B | 361.2B | -268.4B | 84.0B |
Operating Loss: Op. profit -197B
Revenue down 64% YoY
4 Consecutive Years of Net Loss
Debt Ratio Surge (+42pp YoY)
▼ 88.9%
▼ 3.4%
▼ 423.6%
▼ 38.0%
▼ 154.9%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 김성준 | 사내이사 | 사업개발 및 경영총괄 | - |
| 박동석 | 미등기 | 바이오플랜트 | - |
| 김한수 | 미등기 | 고문 | - |
| 임일호 | 미등기 | 고문 | - |
| 김동훈 | 사내이사 | 이사회 의장 | - |
| 최형기 | 사내이사 | 경영관리 | - |
| 김택동 | 사외이사 | 사외이사 | - |
| 나찬기 | 사외이사 | 사외이사 | - |
| 박인엽 | 기타비상무이사 | 기타비상무이사 | - |
| 김치열 | 감사 | 감사 | - |
| 손재호 | 미등기 | 총괄사장 | - |
| 이진희 | 미등기 | 바이오연구소 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| Regular Employees | 42persons |
| CEO | 김성준 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청북도 청주시",
"ceo_name": "손재호",
"certificate": [
{
"cert_number": "20170300644",
"changes": "",
"disclosure_date": "2017-11-23",
"first_cert_date": "2017-11-23",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2017-11-23 ~ 2019-11-22"
},
{
"cert_number": "20190301110",
"changes": "",
"disclosure_date": "2019-11-27",
"first_cert_date": "2017-11-23",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2019-11-23 ~ 2021-11-22"
},
{
"cert_number": "20211110010061",
"changes": "",
"disclosure_date": "2021-11-10",
"first_cert_date": "2017-11-23",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2021-11-23 ~ 2024-11-22"
},
{
"cert_number": "20241113010045",
"changes": "",
"disclosure_date": "2024-11-13",
"first_cert_date": "2017-11-23",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2024-11-23 ~ 2027-11-22"
}
],
"company_name": "주식회사 큐라티스",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 11635956000,
"cost_of_sales": 2769133000,
"current_assets": 11011537000,
"current_liabilities": 36549389000,
"gross_profit": 5640314000,
"net_income": -35758464000,
"net_income_bs": -35758465000,
"non_current_assets": 53481442000,
"non_current_liabilities": 53074430000,
"non_operating_expenses": 14957936000,
"non_operating_income": 681531000,
"operating_profit": -21482059000,
"revenue": 8409446000,
"sga_expenses": 27122373000,
"total_assets": 64492978000,
"total_equity": -25130841000,
"total_liabilities": 89623820000
},
"2023": {
"capital_stock": 21182811000,
"cost_of_sales": 7418454000,
"current_assets": 14931800000,
"current_liabilities": 13097012000,
"gross_profit": -6388396000,
"net_income": -15799242000,
"net_income_bs": -15799242000,
"non_current_assets": 51912325000,
"non_current_liabilities": 14950785000,
"non_operating_expenses": 4098343000,
"non_operating_income": 5542643000,
"operating_profit": -17243542000,
"revenue": 1030058000,
"sga_expenses": 10855146000,
"total_assets": 66844126000,
"total_equity": 38796328000,
"total_liabilities": 28047798000
}
},
"industry": "합성의약품 및 기타 완제 의약품 제조업",
"investment": [
{
"amount": "3,000,000,000",
"changes": "3,000,000,000",
"date": "2021-04-01"
},
{
"amount": "1,999,989,600",
"changes": "1,999,989,600",
"date": "2021-03-11"
},
{
"amount": "2,849,940,000",
"changes": "2,849,940,000",
"date": "2019-01-25"
},
{
"amount": "648,000,000",
"changes": "648,000,000",
"date": "2018-12-28"
},
{
"amount": "1,237,000,000",
"changes": "1,237,000,000",
"date": "2018-12-28"
},
{
"amount": "416,000,000",
"changes": "416,000,000",
"date": "2018-12-28"
},
{
"amount": "2,850,000,000",
"changes": "2,850,000,000",
"date": "2018-11-21"
},
{
"amount": "2,564,946,000",
"changes": "2,564,946,000",
"date": "2018-09-21"
},
{
"amount": "1,241,000,000",
"changes": "1,241,000,000",
"date": "2017-10-20"
}
],
"main_products": "결핵백신",
"phone": "02-866-****",
"years": [
2023,
2022
]
}Data Quality: 9/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-28 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |